3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Sarcoma
1
Conditions
Venous Thromboembolism
18
Neoplasms
11
Venous Thrombosis
9
Pulmonary Embolism
9
Thrombosis
5
Multiple Myeloma
4
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Intracranial Thrombosis
2
Hematologic Neoplasms
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Upper Extremity Deep Vein Thrombosis
1
Thromboprophylaxis
1
Thromboembolism
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Mesenteric Ischemia
1
Leukemia
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Interventions
Gemcitabine
677
130-nm albumin-bound paclitaxel
197
Fluorouracil
184
Oxaliplatin
173
Albumin-Bound Paclitaxel
151
Capecitabine
137
Leucovorin
129
Irinotecan
111
Radiotherapy
95
Taxes
83
pembrolizumab
80
Cisplatin
71
Erlotinib Hydrochloride
69
Radiosurgery
67
Nivolumab
56
Bevacizumab
54
Drug Therapy
52
Cyclophosphamide
48
Magnetic Resonance Spectroscopy
45
folfirinox
42
Docetaxel
41
Cetuximab
40
irinotecan sucrosofate
36
Specimen Handling
36
S 1 (combination)
36
Biopsy
30
Radiation
29
Paclitaxel
29
Ipilimumab
27
Surgical Procedures, Operative
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Pancreatic Neoplasms
×
apixaban
×
Clear all
NCT04191928
2021-12-23
PAP-UP
Thomas Jefferson University
Phase 1
Completed
4 enrolled
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled